The company aims to start a Phase 2 trial for PRX-115 in 2025. Vandana Singh Pfizer's Direct-To-Consumer Model Faces Scrutiny From US Senators (CORRECTED) Senators question Pfizer's partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback